Loading clinical trials...
Loading clinical trials...
Cardiolite-406; A Phase IV Open-Label, Randomized, Multi-Center Trial To Evaluate The Ability of Cardiolite Stress MPI to Detect Asymptomatic Restenosis in Diabetic Patients Who Have Undergone Percutaneous Coronary Intervention
The purpose of this clinical research study is determine if patients with diabetes that have undergone previous opening of a heart blockage may have a blockage that is not causing any symptoms that may be detected by imaging with Cardiolite.
Age
21 - No limit years
Sex
ALL
Healthy Volunteers
No
Local Institution
Hartford, Connecticut, United States
Local Institution
Waterbury, Connecticut, United States
Local Institution
Grand Rapids, Michigan, United States
Local Institution
Roslyn, New York, United States
Local Institution
Burlington, Vermont, United States
Local Institution
Roanoke, Virginia, United States
Local Institution
Wausau, Wisconsin, United States
Local Institution
San Juan, Puerto Rico
Start Date
April 1, 2004
Primary Completion Date
December 1, 2005
Completion Date
December 1, 2005
Last Updated
April 15, 2011
106
ACTUAL participants
Technetium Tc99m Sestamibi
DRUG
Lead Sponsor
Lantheus Medical Imaging
NCT06959901
NCT06574035
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06861062